Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Devalingam MahalingamH Jeffrey Wilkins

Abstract

Transcription factor retinoic acid receptor-related orphan receptor γ (RORγ) regulates type 17 effector T-cell differentiation and function and is key to immune cell regulation. Synthetic RORγ agonists modulate immune cell gene expression to increase effector T-cell activity and decrease immune suppression. A phase 1 study evaluated the safety and tolerability of LYC-55716 (cintirorgon), a first-in-class, oral, small-molecule RORγ agonist in adults with relapsed/refractory metastatic cancer. Patients received 28-day treatment cycles of oral LYC-55716; dose and dosing regimen were determined according to pharmacokinetic profile and safety. Primary endpoints were safety and tolerability. Secondary endpoints included pharmacokinetics and objective tumor response rate. No dose-limiting toxicities occurred among the 32 enrolled patients who received LYC-55716 150 mg BID to 450 mg BID. Treatment-related adverse events (AE) were primarily grade 1-2 and included diarrhea (n = 11), fatigue (n = 7), anemia (n = 4), decreased appetite (n = 4), and nausea (n = 4). Grade 3 AEs were anemia (n = 2), elevated gamma-glutamyl transferase (n = 1), and hypophosphatemia (n = 1). Pharmacokinetic concentrations achieved levels expected for target gen...Continue Reading

References

May 28, 2009·Blood·Christian S HinrichsNicholas P Restifo
Nov 3, 2009·Immunity·Natalia Martin-OrozcoChen Dong
Mar 26, 2010·Nature Reviews. Immunology·Weiping Zou, Nicholas P Restifo
Jul 24, 2010·AJR. American Journal of Roentgenology·Mizuki NishinoAnnick D Van den Abbeele
Oct 15, 2011·Science Translational Medicine·Ilona KryczekWeiping Zou
Dec 20, 2011·Immunity·Pawel MuranskiNicholas P Restifo
Oct 2, 2012·Cell·Maria CiofaniDan R Littman
Mar 29, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrzej T SlominskiAnton M Jetten
Jun 20, 2014·Immunological Reviews·Jeremy P McAleer, Jay K Kolls
Aug 28, 2014·American Journal of Respiratory and Critical Care Medicine·Julie ChesnéAntoine Magnan
Jan 20, 2016·ACS Chemical Biology·Mi Ra ChangPatrick R Griffin
Jan 31, 2016·Cancer Immunology, Immunotherapy : CII·Kinga MajchrzakChrystal M Paulos
May 18, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lawrence H SchwartzLesley Seymour
Mar 9, 2017·The Lancet Oncology·Lesley SeymourUNKNOWN RECIST working group

❮ Previous
Next ❯

Citations

Mar 12, 2020·Immune Network·Da-Sol KuenYeonseok Chung
Oct 30, 2020·Natural Product Reports·Angela LadurnerVerena M Dirsch
Feb 8, 2021·Drug Discovery Today·Matteo Astone, Massimo M Santoro
Feb 28, 2021·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Lukas Gammelgaard RasmussenSönke Detlefsen
Mar 9, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ilaria AttiliFilippo de Marinis
Mar 15, 2021·Trends in Immunology·Jee Hye KangArabella Young
Apr 3, 2021·Journal of Experimental & Clinical Cancer Research : CR·Elizabeth CashVictor C Kok
Mar 31, 2021·Drug Discovery Today·Rodrigo F N RibeiroMaria Manuel C Silva
May 6, 2021·The Journal of International Medical Research·Xiaofei PanYang Li
Aug 3, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·En-Ming TianDi Zhu
Nov 23, 2021·The Journal of Organic Chemistry·Lindsey G DeRattScott D Kuduk
Jan 6, 2022·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio PassaroSolange Peters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.